Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03869645 · ClinicalTrials.gov registry record
CAPERE Thrombectomy System Post-Market Clinical Follow Up Study
A clinical trial, sponsored by Medtronic Endovascular.
- Terminated
- Registry status
- 18
- Enrollment target
NCT03869645 is a clinical trial that was terminated before completion, run by Medtronic Endovascular. The registered enrollment target is 18 participants.
The verdict
NCT03869645 was terminated before completion, sponsored by Medtronic Endovascular.
- TERMINATED
- Registry status
- 18 participants
- Enrollment target
Study Summary
A prospective, single-arm, non-blinded study, intending to collect and evaluate data in up to forty (40) human subjects with acute thrombosis, treated with the CAPERE™ Thrombectomy System.
Interventions
- DEVICE CAPERE Thrombectomy System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2019-06-01 |
| Est. Completion | 2020-08-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03869645
The ClinicalTrials.gov registry entry for NCT03869645 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Endovascular, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CAPERE Thrombectomy System is the first listed.
NCT03869645 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03869645 about?
NCT03869645 is a clinical study titled "CAPERE Thrombectomy System Post-Market Clinical Follow Up Study". A prospective, single-arm, non-blinded study, intending to collect and evaluate data in up to forty (40) human subjects with acute thrombosis, treated with the CAPERE™ Thrombectomy System.
What is the current status of trial NCT03869645?
This trial is currently terminated. The enrollment target is 18 participants. The study started on 2019-06-01. Estimated completion is 2020-08-26.
What interventions are being tested in trial NCT03869645?
The interventions under investigation include: CAPERE Thrombectomy System (DEVICE).
Who is sponsoring clinical trial NCT03869645?
This trial is sponsored by Medtronic Endovascular, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.